Pacific Biosciences Of California Total Non-Operating Income/Expense 2010-2024 | PACB

Pacific Biosciences Of California total non-operating income/expense from 2010 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
Pacific Biosciences Of California Annual Total Non-Operating Income/Expense
(Millions of US $)
2023 $16
2022 $-7
2021 $-64
2020 $134
2019 $16
2018 $-2
2017 $-2
2016 $-3
2015 $-3
2014 $-3
2013 $-2
2012 $-0
2011 $0
2010 $0
2009 $0
Pacific Biosciences Of California Quarterly Total Non-Operating Income/Expense
(Millions of US $)
2024-09-30 $3
2024-06-30 $3
2024-03-31 $3
2023-12-31 $5
2023-09-30 $5
2023-06-30 $3
2023-03-31 $3
2022-12-31 $3
2022-09-30 $-2
2022-06-30 $-3
2022-03-31 $-4
2021-12-31 $-3
2021-09-30 $-4
2021-06-30 $-3
2021-03-31 $-54
2020-12-31 $99
2020-09-30 $0
2020-06-30 $0
2020-03-31 $34
2019-12-31 $18
2019-09-30 $-1
2019-06-30 $-0
2019-03-31 $-0
2018-12-31 $-0
2018-09-30 $-0
2018-06-30 $-1
2018-03-31 $-0
2017-12-31 $-0
2017-09-30 $-0
2017-06-30 $-1
2017-03-31 $-1
2016-12-31 $-1
2016-09-30 $-1
2016-06-30 $-0
2016-03-31 $-1
2015-12-31 $-0
2015-09-30 $-1
2015-06-30 $-1
2015-03-31 $-1
2014-12-31 $-1
2014-09-30 $-1
2014-06-30 $-1
2014-03-31 $-1
2013-12-31 $-0
2013-09-30 $-1
2013-06-30 $-0
2013-03-31 $-0
2012-12-31 $0
2012-09-30 $-0
2012-06-30 $0
2012-03-31 $-0
2011-12-31 $-0
2011-09-30 $0
2011-06-30 $0
2011-03-31 $0
2010-12-31 $0
2010-09-30 $-0
2010-06-30 $-0
2010-03-31 $-0
2009-12-31
2009-09-30 $0
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.493B $0.201B
Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $199.883B 24.39
Intuitive Surgical (ISRG) United States $186.649B 97.58
Edwards Lifesciences (EW) United States $42.814B 27.19
Alcon (ALC) Switzerland $41.161B 27.54
IQVIA Holdings (IQV) United States $35.414B 19.51
IDEXX Laboratories (IDXX) United States $33.479B 39.43
DexCom (DXCM) United States $30.662B 46.18
Waters (WAT) United States $21.866B 32.33
STERIS (STE) Ireland $19.984B 23.01
SONOVA HOLDING (SONVY) Switzerland $19.343B 0.00
Hologic (HOLX) United States $16.281B 17.58
Fresenius Medical Care AG KGaA (FMS) Germany $12.998B 13.34
Sysmex ADR (SSMXY) Japan $11.450B 35.90
Globus Medical (GMED) United States $11.143B 28.22
Penumbra (PEN) United States $9.211B 90.22
Masimo (MASI) United States $9.025B 43.67
Teleflex (TFX) United States $8.316B 13.26
Glaukos (GKOS) United States $8.253B 0.00
Integer Holdings (ITGR) United States $4.433B 25.13
PROCEPT BioRobotics (PRCT) United States $4.340B 0.00
Veracyte (VCYT) United States $3.134B 94.05
Inari Medical (NARI) United States $3.033B 0.00
LivaNova (LIVN) United Kingdom $2.533B 14.62
Tandem Diabetes Care (TNDM) United States $2.354B 0.00
Nihon Kohden (NHNKY) Japan $2.318B 17.61
TransMedics (TMDX) United States $2.232B 70.75
Elekta AB (EKTAY) Sweden $2.095B 18.83
Integra LifeSciences Holdings (IART) United States $1.776B 9.28
RxSight (RXST) United States $1.393B 0.00
Alphatec Holdings (ATEC) United States $1.285B 0.00
Artivion (AORT) United States $1.177B 78.00
Pulse Biosciences (PLSE) United States $1.094B 0.00
OPKO Health (OPK) United States $0.990B 0.00
Paragon 28 (FNA) United States $0.897B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.728B 12.37
AxoGen (AXGN) United States $0.722B 0.00
Mesa Laboratories (MLAB) United States $0.717B 16.90
IRadimed (IRMD) United States $0.696B 37.63
ORTHOFIX MEDICAL INC (OFIX) United States $0.660B 0.00
SiBone (SIBN) United States $0.584B 0.00
OrthoPediatrics (KIDS) United States $0.554B 0.00
Semler Scientific (SMLR) United States $0.506B 26.63
Treace Medical Concepts (TMCI) United States $0.490B 0.00
ClearPoint Neuro (CLPT) United States $0.429B 0.00
Tactile Systems Technology (TCMD) United States $0.411B 22.23
Delcath Systems (DCTH) United States $0.403B 0.00
AngioDynamics (ANGO) United States $0.365B 0.00
NeuroPace (NPCE) United States $0.346B 0.00
CVRx (CVRX) United States $0.330B 0.00
Inogen (INGN) United States $0.219B 0.00
Alpha Tau Medical (DRTS) Israel $0.217B 0.00
Anteris Technologies Global (AVR) Australia $0.199B 0.00
Accuray (ARAY) United States $0.196B 0.00
Sight Sciences (SGHT) United States $0.182B 0.00
KORU Medical Systems (KRMD) United States $0.178B 0.00
Nevro (NVRO) United States $0.139B 0.00
Atossa Genetics (ATOS) United States $0.121B 0.00
Sensus Healthcare (SRTS) United States $0.116B 12.46
LENSAR (LNSR) United States $0.101B 0.00
Spectral Diagnostics (EDTXF) Canada $0.099B 0.00
EDAP TMS S.A (EDAP) France $0.089B 0.00
Vicarious Surgical (RBOT) United States $0.082B 0.00
Monogram Orthopaedics (MGRM) United States $0.082B 0.00
908 Devices (MASS) United States $0.076B 0.00
Hyperfine (HYPR) United States $0.071B 0.00
WORK Medical Technology Group (WOK) China $0.070B 0.00
InspireMD (NSPR) Israel $0.069B 0.00
Covalon Technologies (CVALF) Canada $0.061B 0.00
EnVVeno Medical (NVNO) United States $0.054B 0.00
Spectral AI (MDAI) United States $0.051B 0.00
Lucid Diagnostics (LUCD) United States $0.047B 0.00
Neuronetics (STIM) United States $0.045B 0.00
Rapid Micro Biosystems (RPID) United States $0.042B 0.00
Baird Medical Investment Holdings (BDMD) $0.034B 0.00
Precision Optics (POCI) United States $0.032B 0.00
Accelerate Diagnostics (AXDX) United States $0.032B 0.00
Envoy Medical (COCH) United States $0.031B 0.00
DarioHealth (DRIO) United States $0.028B 0.00
NexGel (NXGL) United States $0.026B 0.00
Biosig Technologies (BSGM) United States $0.024B 0.00
Microbot Medical (MBOT) United States $0.019B 0.00
Adagio Medical Holdings (ADGM) United States $0.017B 0.00
Ekso Bionics Holdings (EKSO) United States $0.014B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.013B 0.00
Aspira Women's Health (AWH) United States $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.011B 0.00
T2 Biosystems (TTOO) United States $0.008B 0.00
PAVmed (PAVM) United States $0.007B 0.00
Check-Cap (CHEK) Israel $0.007B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00